GlassScriptPhysician profile
Leena Lake
NPI 1285861492
$5,475.57
in general payments reported to CMS, 2019-2025
21 companies · $723 in 2025
The $723 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $19.47 · 2021: $161 · 2022: $200 · 2023: $307 · 2024: $3,444 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,737 · Travel and Lodging: $1,736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,737.30 |
| Travel and Lodging | $1,736.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,457.04 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Vertex Pharmaceuticals Incorporated | $175.68 | 2024-2025 | |
| Averitas Pharma INC. | $141.14 | 2023-2025 | Qutenza |
| Vertiflex, INC. | $79.85 | 2019 | |
| Daiichi Sankyo INC. | $75.70 | 2019 | |
| Collegium Pharmaceutical, INC. | $75.09 | 2019-2023 | Belbuca |
| Pfizer INC. | $69.43 | 2019 | |
| Sentynl Therapeutics, INC. | $64.39 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.22 | 2019 | |
| Nevro Corp. | $43.18 | 2023-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.04 | 2019 | |
| Medtronic USA, INC. | $36.96 | 2019 | |
| Medtronic, INC. | $32.73 | 2021 | |
| Vertos Medical, INC. | $23.84 | 2024 | Mild Device Kit |
| Grt US Holding, INC. | $23.27 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $17.69 | 2022 | |
| Abbvie INC. | $17.28 | 2024 | |
| Assertio Therapeutics, INC. | $17.25 | 2019 | |
| Shionogi INC | $16.51 | 2019 | |
| Horizon Therapeutics Plc | $12.41 | 2019 | |
| Biodelivery Sciences International, INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leena Lake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.